Telmisartan Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2E2-24-R-0015
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents5
The Defense Logistics Agency (DLA) Troop Support has issued an active solicitation (Procurement Identifier: SPE2E2-24-R-0015) for the supply of Telmisartan Tablets, a pharmaceutical product classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505. This procurement seeks qualified manufacturers or suppliers capable of providing Telmisartan Tablets in accordance with federal requirements and specifications.
The purpose of this solicitation is to ensure the reliable acquisition and supply of Telmisartan Tablets, which are essential for supporting the health and medical needs of military personnel and other federal beneficiaries. The scope of the procurement encompasses the manufacturing, packaging, and delivery of pharmaceutical-grade Telmisartan Tablets, with the expectation that all products will meet stringent quality standards and regulatory compliance as outlined in the solicitation documents.
Amendment 0004 has been issued to accommodate changes in the solicitation, pursuant to the authority of CD 2025-O0003 and CD 2025-O0004. Contractors are advised to review all amendments and associated attachments (five are currently available via the SAM.gov opportunity listing) to ensure full compliance with updated requirements.
Key requirements for this opportunity include demonstrated capability in pharmaceutical preparation manufacturing, adherence to applicable federal regulations, and the ability to deliver consistent, high-quality Telmisartan Tablets. The contracting entity, DLA Troop Support, operates as a federal office and is responsible for overseeing the procurement process and contract administration.
Interested parties should note the following details:
- Solicitation Type: Federal solicitation for pharmaceutical products
- Set-Aside Requirements: Not specified in the provided information
- Special Considerations: Contractors must comply with all amendments and referenced authorities
- Location: Not specified, but managed by DLA Troop Support (federal office)
- Contact Information:
- Primary Contact: Courtney Hunter-Stangler ([email protected])
- Secondary Contact: Jason Wray ([email protected], phone: 445-737-6304)
- Response Deadline: February 28, 2025, at 20:02
- Notice URL: https://sam.gov/opp/b0ce3edc9507417bb4030bab33ef8d79/view
Contractors evaluating this opportunity should ensure their capabilities align with the pharmaceutical manufacturing requirements and be prepared to address all solicitation amendments. The contract will require ongoing compliance with federal standards and consistent product quality throughout its lifecycle. For further details and to access solicitation attachments, interested parties should refer to the official SAM.gov listing.